Dr Philip DayPhD, FRSB, FRSC

Reader

Full contact details
View graph of relations

Research interests

Philip Day is Reader in Quantitative Analytical Genomics at Manchester University, Director of the Quantitative Molecular Medicine Group and Principle Investigator at the Manchester Institute of Biotechnology, and a member of the Centre for Epidemiology and CIGMR, at the Medical Faculty. He currently is developing synthetic biology and chemical biology approaches to directed evolution of novel proteins and aptamers for biomedical applications. These are used in combination with expertise for building integrated pathogenesis models of CML. Other closely related studies concern the enhanced uptake of anti-cancer drugs through membrane associated transporters, and Philip maintains an academic interest in the biological significance of heterogeneity. 

Methodological knowledge

qPCR

molecular biology

Assay development

sample preparation and handling

Single cell analysis, homogeneous sample handling

Aptamer development

Systems biology/medicine

Chemical biology

Synthetic biology

Projects

Research and projects

No current projects are available for public display